The results in Table 1 show the same frequency of mice developing tumour (88% with the IGR-CaP1 shGal-8.1, 80% with the IGR-CaP1 shGal-8.2 versus 83% with the shCtrl), and no significant differences were found neither in the time span required to detect palpable tumours (i.e. the latency period) nor in tumour growth (Table 1: duplication time, Figure 5b). Here, CAP1 is linked to neoplasm.